NCT06565351View on ClinicalTrials.gov

S-cystatin C vs.Injection Clearance Measurements to Estimate Kidney Function in Patients With Spinal Cord Injuries

CompletedOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions
Spinal Cord InjuriesRenal Failure
Interventions
OTHER

eGFR estimated from creatinine and cystatin C

eGFR estimated from creatinine and cystatin C was compared to GFR measured by 99mTc-DTPA clearance (gold standard)

Trial Locations (1)

DK-2600

Dept. of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet; Glostrup, Glostrup Municipality

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT06565351 - S-cystatin C vs.Injection Clearance Measurements to Estimate Kidney Function in Patients With Spinal Cord Injuries | Biotech Hunter | Biotech Hunter